参考文献/References:
[1] 阎丽,付婷.子宫肌瘤患者子宫动脉血流动力学指标与子宫体积关系及对肌瘤变性诊断效能研究[J].陕西医学杂志,2023,52(5):545-548.
[2] 赵瑾,周艳红,白小英.子宫肌瘤患者凝血功能与子宫体积关系及其对继发性贫血的预测价值研究[J].陕西医学杂志,2022,51(2):164-167.
[3] ALI M,STONE D,LAKNAUR A,et al.EZH2 activates Wnt/β-catenin signaling in human uterine fibroids,which is inhibited by the natural compound methyl jasmonate[J].F S Sci,2023,4(3):239-256.
[4] 谭建福,饶丽娟.枸杞多糖调控Wnt信号通路对子宫肌瘤细胞生物活性的影响[J].中国免疫学杂志,2022,38(19):2346-2351.
[5] 郝子兰,马惠荣,林雄坡,等.女性子宫肌瘤发病危险因素的Meta分析[J].中国性科学,2023,32(2):64-68.
[6] 牟敏,翁波,何常佑,等.单次注射右美托咪定对子宫肌瘤腹腔镜手术患者应激反应血清基质金属蛋白酶9髓鞘碱性蛋白水平的影响[J].山西医药杂志,2022,51(12):1394-1397.
[7] 赵璟文,范可辽,邰迎春.他莫昔芬对子宫肌瘤大鼠血清前列腺素E2和前列腺素F2α的影响及机制研究[J].临床和实验医学杂志,2022,21(21):2257-2260.
[8] 蒋国庆,周应芳.子宫腺肌病的诊疗新进展[J].中国妇产科临床杂志,2002,3(2):125-127.
[9] 陈茜松,柴静,王丹,等.米非司酮联合左炔诺孕酮宫内缓释系统对子宫肌瘤患者单核细胞趋化因子-1水平的影响[J].中国药业,2021,30(13):56-59.
[10] 关琼,杨爱玉,吴绪峰.子宫腺肌病患者在醋酸亮丙瑞林基础上联合左炔诺孕酮宫内节育系统或地诺孕素治疗的效果比较[J].中国医药,2023,18(1):86-90.
[11] 张瑾,杨帆,郑雪绒,等.活血消癥汤配合针灸及子宫动脉介入栓塞术治疗子宫肌瘤临床研究[J].陕西中医,2022,43(11):1617-1620.
[12] 史红杰,张兴伟,马二梅,等.逐瘀消癥方治疗子宫肌瘤疗效及对患者细胞凋亡蛋白和雌、孕激素受体表达的影响[J].陕西中医,2020,41(11):1559-1562.
[13] VAFAEI S,CIEBIERA M,OMRAN M M,et al.Evidence-based approach for secondary prevention of uterine fibroids(the escape approach)[J].Int J Mol Sci,2023,24(21):15972.
[14] ACQUILANO S C,FORCINO R C,SCHUBBE D,et al.The costs of implementing a conversation aid for uterine fibroids in multiple health care settings[J].Med Care,2023,61(10):689-698.
[15] BABUNASHVILI E L,SON D Y,BUYANOVA S N,et al.Outcomes of laparotomic myomectomy during pregnancy for symptomatic uterine fibroids:A prospective cohort study[J].J Clin Med,2023,12(19):6406.
[16] 王晓娟,董娜,徐鹏育.子宫内膜癌组织中GATA结合蛋白3、人附睾蛋白4的表达及临床意义[J].癌症进展,2023,21(5):517-520,573.
[17] 石小哲,马宏丰,赵先兰.黏蛋白4在子宫内膜癌中的表达及临床意义[J].实用肿瘤杂志,2020,35(1):65-68.
[18] 徐青,付子毅,马慧媛,等.LNG-IUS治疗子宫肌瘤的临床效果及机制探讨[J].中国计划生育学杂志,2018,26(4):274-278.
[19] 张同美,李会荣.他莫昔芬联合米非司酮对围绝经期子宫肌瘤的疗效及血清性激素水平的影响[J].药物评价研究,2018,41(4):603-606.
[20] 吴文钰,李斐斐,CHUNG S,等.中西医治疗乳腺癌术后他莫昔芬相关子宫内膜病变研究进展[J].陕西中医,2023,44(12):1831-1832,封3.
[21] 王琴,陈林伟,江勇,等.基于Med12/Wnt/β-Catenin信号通路的气血双补方治疗子宫肌瘤的作用机制[J].中国医院药学杂志,2023,43(13):1442-1446.
[22] CARBAJO-GARCÍA M C,JUAREZ-BARBER E,SEGURA-BENÍTEZ M,et al.H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes,synapsis components,proliferation,and Wnt/β-catenin and TGF-β pathways[J].Reprod Biol Endocrinol,2023,21(1):9.
[23] 王超,安瑞芳,何菊仙,等.GnRH类似物对子宫肌瘤大鼠模型血液黏度、子宫系数和炎性细胞浸润的影响[J].现代生物医学进展,2022,22(4):632-636.
[24] 张晓敏,伦明辉,黄泽清.长托宁联合米非司酮通过下调Wnt/β-catenin通路调节子宫肌瘤大鼠雌激素减轻子宫损伤[J].解剖科学进展,2022,28(2):113-116,120.
[25] 瞿秋红,韦立蓓,尹伶.下调TPD52基因表达通过Wnt信号通路对子宫肌瘤细胞活力、凋亡及TNF-α和IL-6表达的影响[J].中国病理生理杂志,2019,35(1):87-92.
相似文献/References:
[1]赵 瑾,周艳红,白小英.子宫肌瘤患者凝血功能与子宫体积关系及其对继发性贫血的预测价值研究[J].陕西医学杂志,2022,51(2):164.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.008]
ZHAO Jin,ZHOU Yanhong,BAI Xiaoying.Relationship between coagulation function and uterine volume in patients with uterine fibroids and its predictive value for secondary anemia[J].,2022,51(5):164.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.008]
[2]高香转,邸 曼,李 楚,等.血栓弹力图参数与子宫肌瘤病情严重程度关系及对贫血风险的评估价值[J].陕西医学杂志,2023,52(3):278.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.007]
GAO Xiangzhuan,DI Man,LI Chu,et al.Relationship between thrombelastography parameters and the severity of uterine fibroidsand its value in evaluating the risk of anemia[J].,2023,52(5):278.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.007]
[3]阎 丽,付 婷.子宫肌瘤患者子宫动脉血流动力学指标与子宫体积关系及对肌瘤变性诊断效能研究[J].陕西医学杂志,2023,52(5):545.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.011]
YAN Li,FU Ting.Relationship between uterine arterial hemodynamics and uterine volume in patients with uterine fibroids and the diagnostic efficacy of fibroid degeneration[J].,2023,52(5):545.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.011]
[4]汤友苗,孔成才,范文秀,等.白果内酯对子宫肌瘤细胞及裸鼠移植瘤的影响实验研究[J].陕西医学杂志,2025,54(2):152.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.002]
TANG Youmiao,KONG Chengcai,FAN Wenxiu,et al.Effects of bilobalide on uterine leiomyoma cells and transplantable tumors in nude mice[J].,2025,54(5):152.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.002]